These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7709093)

  • 1. [Moraxella bovis biomass production in a bench-top fermentor].
    González RD; Oberti ER
    Rev Latinoam Microbiol; 1994; 36(3):177-81. PubMed ID: 7709093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of bovine carriers of Moraxella bovis by comparative cultural examinations of ocular and nasal secretions.
    Pugh GW; McDonald TJ
    Am J Vet Res; 1986 Nov; 47(11):2343-5. PubMed ID: 3789493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An outbreak of keratoconjunctivitis in a dairy farm].
    van Weering HJ; Koch MJ
    Tijdschr Diergeneeskd; 1992 Feb; 118(3):82-4. PubMed ID: 1287897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of naturally occurring infectious bovine keratoconjunctivitis with a recombinant Moraxella bovis pilin-Moraxella bovis cytotoxin-ISCOM matrix adjuvanted vaccine.
    Angelos JA; Bonifacio RG; Ball LM; Hess JF
    Vet Microbiol; 2007 Dec; 125(3-4):274-83. PubMed ID: 17656049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine against infectious bovine keratoconjunctivitis: a new approach to optimize the production of highly piliated Moraxella bovis cells.
    Prieto CI; Bosch A; Zielinski G; Cúneo J; Yantorno OM
    Vaccine; 2008 Dec; 26(51):6542-9. PubMed ID: 18852003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moraxella bovis pathogenicity: an update.
    Postma GC; Carfagnini JC; Minatel L
    Comp Immunol Microbiol Infect Dis; 2008 Nov; 31(6):449-58. PubMed ID: 18514312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenicity and immunogenicity of piliated and nonpiliated phases of Moraxella bovis in calves.
    Jayappa HG; Lehr C
    Am J Vet Res; 1986 Oct; 47(10):2217-21. PubMed ID: 2877604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of tulathromycin for treatment of cattle with acute ocular Moraxella bovis infections.
    Lane VM; George LW; Cleaver DM
    J Am Vet Med Assoc; 2006 Aug; 229(4):557-61. PubMed ID: 16910856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relatedness of cytotoxins from geographically diverse isolates of Moraxella bovis.
    Angelos JA; Ball LM
    Vet Microbiol; 2007 Oct; 124(3-4):382-6. PubMed ID: 17540518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Moraxella bovis and related species from calves with IBK and goats by qualitative genetic transformation assay.
    Kodjo A; Exbrayat P; Richard Y
    Zentralbl Veterinarmed B; 1994 Jul; 41(5):336-43. PubMed ID: 7839756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of biofilm-forming capacity of Moraxella bovis, the primary causative agent of infectious bovine keratoconjunctivitis.
    Prieto C; Serra DO; Martina P; Jacobs M; Bosch A; Yantorno OM
    Vet Microbiol; 2013 Oct; 166(3-4):504-15. PubMed ID: 23907059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-glucan production by Botryosphaeria rhodina in different bench-top bioreactors.
    Selbmann L; Crognale S; Petruccioli M
    J Appl Microbiol; 2004; 96(5):1074-81. PubMed ID: 15078524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infection rates, disease frequency, pilin gene rearrangement, and pilin expression in calves inoculated with Moraxella bovis pilin-specific isogenic variants.
    Ruehl WW; Marrs CF; George L; Banks SJ; Schoolnik GK
    Am J Vet Res; 1993 Feb; 54(2):248-53. PubMed ID: 8094276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of cytokines as adjuvants of infectious bovine keratoconjunctivitis vaccines.
    di Girolamo FA; Sabatini DJ; Fasan RA; Echegoyen M; Vela M; Pereira CA; Maure P
    Vet Immunol Immunopathol; 2012 Jan; 145(1-2):563-6. PubMed ID: 22264735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Infectious bovine keratoconjunctivitis (IBK) in cows, clinical and lab review at four farms].
    Holzhauer M; Visser IJ; van Maanen K
    Tijdschr Diergeneeskd; 2004 Aug; 129(16):526-9. PubMed ID: 15347189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infectious bovine keratoconjunctivitis epizootic associated with area-wide emergence of a new Moraxella bovis pilus type.
    Vandergaast N; Rosenbusch RF
    Am J Vet Res; 1989 Sep; 50(9):1437-41. PubMed ID: 2572190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serologic cross-reactivity of Australian Moraxella bovis to vaccinal bacterin strains as determined by competitive ELISA.
    McConnel CS; Shum L; Gleeson BL; House JK
    Aust Vet J; 2008 Apr; 86(4):124-9. PubMed ID: 18363984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the virulence of various strains of Moraxella bovis.
    Pugh GW; Hughes DE
    Can J Comp Med; 1970 Oct; 34(4):333-40. PubMed ID: 4249096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infectious bovine keratoconjunctivitis: a review of cases in clinical practice.
    Alexander D
    Vet Clin North Am Food Anim Pract; 2010 Nov; 26(3):487-503. PubMed ID: 21056797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial susceptibility of Australian bovine Moraxella isolates.
    McConnel CS; Shum L; House JK
    Aust Vet J; 2007; 85(1-2):70-1. PubMed ID: 17300465
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.